Beruflich Dokumente
Kultur Dokumente
0 Sessions of Interest
High
Medium
Low
Other
Ranking
Programs related to Patiromer, ZS-9, and highly-relevant hyperkalemia
topics
Programs related to hyperkalemia, the RAASi system, RAASi and
LCZ696, and relevant diseases including HF,HTN, or CKD with possible
link to hyperkalemia including treatment options, complications,
outcomes
Programs on pathophysiology of relevant diseases (HTN, HF, CKD),
RAASi or RAAS system with no clear link to potassium or disease
outcomes
Programs on biomarkers, healthcare economics, clinical trials,
publications or technology related to HF and/or CKD
Wednesday, November 16
Session Title
Time
Diagnosis and
Management of
Disorders of Acid-Base,
Fluid, and Electrolyte
Balance: Challenging
Issues for the Clinician
7:30am
6:00pm
Speakers
Treatment of Dyskalemias; Questions and Answers
01:00 PM - 02:00 PM
Thomas D. DuBose, MD, FASN, Winston-Salem, NC
Selection of Fluid Therapy in Patients with Medical or
Surgical Conditions; Questions and Answers
02:00 PM - 03:00 PM
Biff F. Palmer, MD, FASN, Dallas, TX
Break
03:00 PM - 03:30 PM
Treatment of Acute Disorders of Magnesium,
Calcium, and Phosphorus Balance; Questions and
Answers
03:30 PM - 04:30 PM
David A. Bushinsky, MD, Rochester, NY
Illustrative Cases
04:30 PM - 05:30 PM
David A. Bushinsky, MD, Rochester, NY
Thomas D. DuBose, MD, FASN, Winston-Salem, NC
Biff F. Palmer, MD, FASN, Dallas, TX
Questions and Answers
05:30 PM - 06:00 PM
David A. Bushinsky, MD, Rochester, NY
Thursday, November 17
Session
Title
Opening
Plenary:
President's
Address,
Former
Councilors
Recognition,
ASN/ERAEDTA/ISN
Declaration of
Collaboration,
State-of-the-Art
Lecture
Giving and
Receiving: Role
of the Physician
in Patient
Transitions of
Care, Including
the Christopher
R. Blagg, MD,
Lectureship in
Renal Disease
and Public
Policy
Time
Locatio
n
Speakers
President's Address
08:00 AM - 08:30 AM
Raymond C. Harris, MD, FASN, Nashville, TN
Former Councilors Recognition
08:30 AM - 08:45 AM
8:009:30am
W375C-E
ASN/ERA-EDTA/ISN Declaration of
Collaboration
08:45 AM - 08:50 AM
State-of-the-Art Lecture "The Causes and
Consequences of Human Obesity: Lessons
from Genetics
08:50 AM - 09:30 AM
Stephen O'Rahilly, MD, Cambridge, United
Kingdom
Chairs:
Rebecca J. Schmidt, DO, FASN, Morgantown,
WV
Suzanne Watnick, MD, Portland, OR
Optimizing Transitions for our Patients in and
out of the Hospital
10:30-11:00am
David Meltzer MD, PhD, Chicago, IL
10:3012:30pm
W179
Chair:
Sharon G. Adler, MD, FASN, Los Angeles, CA
Prevention and
Treatment of
Chronic
Hyperkalemia
Introduction
12:45-12:55pm
Sharon G. Adler, MD, FASN, Los Angeles, CA
12:451:45pm
S100A
**Supported by
Relypsa
A Balanced
Approach to
Phosphorus
Balance
CKD-MBD
Guideline
Update: A
Critical
Appraisal of
Recent Studies
12:451:45pm
Regency
Ballroom
12:451:45pm
W196
Indianapolis, IN
Questions and Answers
1:35-1:45pm
Chairs:
Yong-Lim Kim, MD, Ph D, Jung-gu, Daegu
Peter Margetts, MD, PhD, Hamilton, Ontario,
Canada
Advances in Understanding of Peritoneal
Fibrosis
2:00-2:30pm
Shuei-Liong Lin, MD, PhD, Taipei, Taiwan
Peritoneal
Dialysis and a
Scarred Belly
2:004:00pm
W184
2:004:00pm
W185
Nephrology
Quiz and
Questionnaire
2:004:00pm
W375B
Glomerular Diseases
2:30-3:00pm Andrew S. Bomback, MD, MPH,
New York, NY
Transplantation
3:00-3:30pm Margaret J. Bia, MD, New Haven,
CT
Renal Replacement Therapy
3:30-4:00pm
Charmaine E. Lok, MD, MPH, Toronto, Ontario,
Canada
Chairs:
Michael Allon, MD, Birmingham, Alabama
Jerry Yee, MD, FASN, Detroit, Michigan
Beyond the Guidelines: Patient Irrelevance?
2:00-2:30pm
Louis M. Moist, MD, London, Canada
Discompuzzled:
What to Do
When Practice
and Evidence
Don't Align
Making
Nephrology an
On-Study
2:004:00pm
S102
2:004:00pm
W183C
Specialty:
Challenges and
Opportunities
SPRINTing to
New BP
Treatment
Goals
2:004:00pm
W375A
Clinical and
Translational
Science to
2:004:00pm
W192
Reduce Health
Disparities
Dialysis
Outcomes and
Practice
Patterns Study
Program:
Celebrating 20
Years and
Looking Ahead
Paradigm Shifts
in Diabetic
4:306:30pm
W375A
4:306:30pm
W375B
Mexico
Kidney Disease
Patient-Centric
Approaches to
Kidney Disease
Innovation
4:306:30pm
W184
4:306:30pm
4:306:30pm
4:306:30pm
S103
W187
W183A
Biomarkers and
Treatments of
CKD
CKD: Mental
Health, Quality
of Life, Health
Services,
Disparities
4:306:30pm
W179
4:306:30pm
W183B
Friday, November 18
Session
Title
Plenary: ASN
Foundation for
Kidney
Research
Recognition,
Diamond Level
Corporate
Supporters
Recognition,
Former Award
Recipients,
Recognition,
State of the Art
Lecture
What Do the
Large
Nephrology
Databases Tell
Us?
Implications for
Future Kidney
Care
Time
Locatio
n
Speakers
ASN Foundation for Kidney Research
Announcement
8:00-8:10am
8:009:30am
W375C-E
Former Award Recipients Recognition
8:15-8:45am
State-of-the-Art Lecture "Reflex Circuits in
Immunity: Bioelectronic Medicine"
8:45-9:25am
Kevin J. Tracey, MD, Manhasset, NY
10:3012:30pm
W178
Chairs:
Kevin F. Erickson, MD, MS, Houston, TX
Wolfgang C. Winkelmayer, MD, PhD, MPH,
Houston, TX
DOPPS: Recent Findings and Implications for
the Future of Kidney Care Delivery
10:30-11:00am
Francesca Tentori, MD, Ann Arbor, MI
PEER: Recent Findings and Implications for the
Future of Kidney Care Delivery
11:00-11:30am
Allan J. Collins, MD, Minneapolis, MN
USRDS: Recent Findings and Implications for
the Future of Kidney Care Delivery
11:30-12:00pm
Getting on Your
Nerves: Role of
Sympathetic
and
Parasympatheti
c Outflow in
Hypertension
and CKD
10:3012:30pm
W190A
Home
Hemodialysis:
Alpha to Omega
Biomarker
Identification
and Validation
in the
10:3012:30pm
10:3012:30pm
W375B
W192
Management of
CKD, Including
the Robert W.
Schrier, MD,
Endowed
Lectureship
Expanding the
Therapeutic
Armamentariu
m for Treatment
of Anemia of
Kidney Disease
KDIGO
Guidelines in
CKD-Mineral
and Bone
Disorder: Time
for
Reassessment?
12:451:45pm
S100A
12:451:45pm
Regency
Ballroom
Fluid
Management in
Hemodialysis:
Determining
the Goal and
Reaching It
Introduction
12:45-12:55pm
Areef Ishani, MD, Minneapolis, MN
12:451:45pm
S100B-C
Approach to the
Management of
Acute and
Chronic
Hyperkalemia
in the
Complicated
Patient
Introduction
12:45-12:55pm
Linda F. Fried, MD, FASN, MPH, Pittsburgh, PA
12:451:45pm
S401
**Supported by
ZS
Highlights from
2:00-
S103
ERA-EDTA
Congress in
Vienna
Transplantation
2:00-2:30pm
Rainer Oberbauer, MD, FASN, Vienna, Austria
CKD/Nutrition
2:30-3:00pm
Denis Fouque, MD, PhD, Lyon, France
4:00pm
Dialysis
3:00-3:30pm
Peter J. Blankestijn, MD, FASN, Groningen,
Netherlands
Glomerulonephritis/Immunology
3:30-4:00pm
David R.W. Jayne, MD, Cambridge, UK
Chairs:
L. Ebony Boulware, MD, MPH, Durham, NC
Leslie P. Wong, MD, FASN, Cleveland, OH
iPatient:
Providing
Kidney Care via
Telehealth
2:004:00pm
W190B
Marching
Forward with
New Treatments
for Old Ailments
2:004:00pm
W185
Feeling the
Pinch of Salt:
Intrarenal
ReninAngiotensin
System and
Hypertension
Management of
Diabetes in
Diabetic Kidney
Disease: Are
We Doing It
Right?
2:004:00pm
2:004:00pm
S105
W179
PhysiologyBased
Approach to
Management of
Common
Electrolyte
Disorders
Hypertension
Challenges
across the
Spectrum of
CKD
Bridging the
Gap between
Evidence and
Practice of
Peritoneal
Dialysis
Hyponatremia
2:00-2:30pm
Tomas Berl, MD, FASN. Denver, CO
2:004:00pm
S102
Hyperkalemia
2:30-3:00pm
Csaba P. Kovesdy, MD, Memphis, TN
Diabetic Ketoacidosis
3:00-3:30pm
Mitchell L. Halperin, MD, Toronto, ON
4:306:30pm
4:306:30pm
W375B
W375A
Hypercalcemia
3:30-4:00pm
R. Tyler Miller, MD, Dallas, TX
Chairs: Debbie L. Cohen, MD, Philadelphia, PA
Abhijit V. Kshirsagar, MD, MPH, Chapel Hill, NC
Dont Let Me Down: Re-Evaluating Blood
Pressure Goals for Treated Hypertension in
CKD4:30-5:00pm Csaba P. Kovesdy, MD,
Memphis, TNTo ARB or Not to ACE-I: Which
Agent Should Be the First for Treating
Hypertension in CKD?5:00-5:30pm Sankar D.
Navaneethan, MD, MS, FASN, MPH, Cleveland,
OH
Hypertension in Dialysis: Is it All Salt
and Water?5:30-6:00pm Jennifer E. Flythe,
MD, FASN, MPH, Chapel Hill, NC
Hypertension in Kidney Transplantation6:006:30pm Sarah L. Elfering, MD, Minneapolis,
MN
Chairs:
Mark Lambie, MBChB, PhD, Staffordshire, UK
Roberto Pecoits-Filho, MD, PhD, FASN,
Curitiba, Paran, Brazil
PD Survival in the First Year and a Targeted
Approach to Prolong Time on Therapy
4:30-5:00pm
Sodium on the
Podium: The
Kidney in
Hypertension
PatientCentered
Outcomes with
Maintenance
Dialysis
GFR Estimation
and CKD
Epidemiology
for NonCardiovascular
End Points
4:306:30pm
W190B
4:306:30pm
W185
4:306:30pm
W179